Type II amiodarone-induced thyrotoxicosis and concomitant papillary cancer of the thyroid.
Cattaneo
F
F
D000368:Aged; D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy; D002291:Carcinoma, Papillary / Q000139:chemically induced* / Q000175:diagnosis / Q000601:surgery; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D006801:Humans; D008297:Male; D013964:Thyroid Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000601:surgery; D013965:Thyroidectomy; D013971:Thyrotoxicosis / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis / Q000601:surgery; D013974:Thyroxine / Q000097:blood
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone; D013974:Thyroxine